Rod Monroy, Ph.D
Dr Monroy joined Xenotherapeutics in 2017 after spending more than 11 years leading cell therapy clinical research of mesenchymal stem cells and hepatocytes at Osiris and Cytonet. Previously, he served as director of research efforts in hematopoietic chimerism and immunological responses in xenotransplantation studies in non-human primate models at Biotransplant. Dr Monroy’s began his scientific career studying radiation, stem cell biology and transplantation in the U.S. Navy.
Dr Monroy received his Ph.D. in Biochemistry at Case Western Reserve University.